Quantcast
Connect with us

Jeb Bush tells Chuck Todd he’s ‘conflicted’ about the death penalty and that it needs reform

Published

on

Republican presidential candidate Jeb Bush said he is conflicted about the death penalty and wants to see reforms in how it is implemented.

Bush, in an interview taped for broadcast on Sunday on NBC’s “Meet the Press,” said executions can provide closure for families of murder victims but that other issues are involved.

“It’s hard for me, as a human being, to sign the death warrant, to be honest with you,” he said. “I’m informed by my faith in many things, and this is one of them. So I have to admit that I’m conflicted about this.”

ADVERTISEMENT

“But we should reform it. If it’s to be used as a deterrent, it has to be reformed. It can’t take 25 years (of legal appeals before an execution). That does no one any good. Neither the victims nor the state is solving this problem with that kind of tangled judicial process.”

Florida executed 20 murderers while Bush was the state’s governor from 1999 to January 2007, according to the database of the Death Penalty Information Center.

Republican candidates generally have supported the death penalty while Democratic presidential candidate Hillary Clinton has said it should be re-examined and her main challenger, Vermont Senator Bernie Sanders, has called for its abolition.

Bush’s campaign has been troubled by lackluster debate performances, sagging poll numbers and recent cutbacks in staff and salaries of his campaign organization. He also has faced criticism from Republican rival candidate Donald Trump for being “low energy” and critics have questioned if he has the personality and resolve to carry a campaign through to the November 2016 election.

Bush said on “Meet the Press” he did not know why pundits questioned his drive to be president but said he needed to improve his performance.

ADVERTISEMENT

“Look, I know that I’ve got to get better at doing the debate,” he said. “I’m a grinder. I mean, when I see that I’m not doing something well then I reset and I get better. And I’m going to be better.”

(Writing by Bill Trott; Editing by James Dalgleish)

Watch the full 30-minute inteview below:

ADVERTISEMENT


Report typos and corrections to: [email protected].
READ COMMENTS - JOIN THE DISCUSSION
Continue Reading

2020 Election

Democrats and Never-Trumpers gaming out ‘doomsday scenarios’ if president refuses to leave office: report

Published

on

According to a report in the New York Times, Democratic strategists and Never-Trumper conservatives fear Donald Trump will refuse to leave office should he lose in November and are making plans and figuring out their legal options should such an unprecedented state of affairs come to pass.

The report, by the Times' Reid Epstein, begins with one such possible scenario.

Continue Reading

COVID-19

‘Retaliation plain and simple’: Vaccine agency top Doc fired by Trump administration files whistleblower complaint

Published

on

Dr. Rick Bright has retained an attorney and will be filing a whistleblower complaint after the Trump administration fired him from his position as head of the federal agency charged with developing a COVID-19 vaccine. Dr. Bright was moved to a different agency with a narrower focus after he raised concerns over President Donald Trump's obsession with promoting hydroxychloroquine, a malaria drug recent studies found doubles the death rate in coronavirus patients.

Continue Reading
 

COVID-19

Checking blood for coronavirus antibodies – 3 questions answered about serological tests and immunity

Published

on

Coronavirus testing in the United States is moving into a new phase as scientists begin looking into people’s blood for signs they’ve been infected by SARS-CoV-2, the virus that causes COVID-19. This technique is called serological testing.

Virologist Daniel Stadlbauer helped develop a serological test to detect SARS-CoV-2 antibodies and helped transfer it from the research lab to the clinical setting. Epidemiologist Aubree Gordon regularly uses serological assays in her research studies on influenza and dengue fever. She’s now established serological testing for SARS-CoV-2 in her research lab.

Continue Reading
 
 
You need honest news coverage. Help us deliver it. Join Raw Story Investigates for $1. Go ad-free.
close-image